First Time Loading...

Fate Therapeutics Inc
NASDAQ:FATE

Watchlist Manager
Fate Therapeutics Inc Logo
Fate Therapeutics Inc
NASDAQ:FATE
Watchlist
Price: 4.23 USD 1.93% Market Closed
Updated: May 14, 2024

Fate Therapeutics Inc
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Fate Therapeutics Inc
Selling, General & Administrative Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
Fate Therapeutics Inc
NASDAQ:FATE
Selling, General & Administrative
-$81.4m
CAGR 3-Years
-34%
CAGR 5-Years
-39%
CAGR 10-Years
-28%
Abbvie Inc
NYSE:ABBV
Selling, General & Administrative
-$12.7B
CAGR 3-Years
-4%
CAGR 5-Years
-11%
CAGR 10-Years
-9%
Gilead Sciences Inc
NASDAQ:GILD
Selling, General & Administrative
-$6.1B
CAGR 3-Years
-6%
CAGR 5-Years
-8%
CAGR 10-Years
-13%
Amgen Inc
NASDAQ:AMGN
Selling, General & Administrative
-$6.7B
CAGR 3-Years
-6%
CAGR 5-Years
-5%
CAGR 10-Years
-3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Selling, General & Administrative
-$1.1B
CAGR 3-Years
-14%
CAGR 5-Years
-15%
CAGR 10-Years
-12%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Selling, General & Administrative
-$2.7B
CAGR 3-Years
-25%
CAGR 5-Years
-12%
CAGR 10-Years
-23%

See Also

What is Fate Therapeutics Inc's Selling, General & Administrative?
Selling, General & Administrative
-81.4m USD

Based on the financial report for Dec 31, 2023, Fate Therapeutics Inc's Selling, General & Administrative amounts to -81.4m USD.

What is Fate Therapeutics Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-28%

Over the last year, the Selling, General & Administrative growth was 3%. The average annual Selling, General & Administrative growth rates for Fate Therapeutics Inc have been -34% over the past three years , -39% over the past five years , and -28% over the past ten years .